RSU1 expression was blocked by miR-182 in lung metastasis of mouse fibrosarcomas, as well as in a breast cancer cell line [17,18], and miR-629 targeted RSU1 in cervical cancer thereby decreasing the sensitivity to a therapeutic agent [19]. This evidence concerns the gene RSU1 and fibrosarcoma.